Fifth Annual BioE2E Alternative Funding Fair

• October 7, 2006: 8:00am - 2:00pm
• More Information: http://www.qb3.org
• Location: Byers Auditorium, Genentech Hall, UCSF Mission Bay Campus

In today's tough environment for VC funding, entrepreneurs need to access alternative funding sources ' including government agencies and foundations. US and state government agencies and philanthropic foundations provide funds and non-cash resources to small biotechnology companies with innovative technologies in the form of grants, contracts, screening services and other development assistance. Government grants and contracts can provide non-dilutive funding, validation from peers, feedback from experts and prestige, while services help you to advance programs while conserving cash.

Invited speakers and topics include:

* Defense Sciences Office, DARPA
* Michael Callahan MD, Program Manager
* The Joint Development Program (JTD) for Cancer Drug Development
* Joseph Tomaszewski, PhD, Deputy Director, Division of Cancer Treatment and Diagnosis (DCTD), National Cancer Institute
* Industry-University Collaborations
* Susanne Huttner, PhD, University of California Associate Vice Provost for Research
* Building your Company Without VC Money
* Dan Schwartz, MD, Founder, Calhoun Vision, Inc. and Associate Professor and Director of the Retina Division in the Department of Ophthalmology at UCSF
* Solicitations, Strategies and Discourse: Keys to Success for Funds
* Cori Gorman, PhD MBA, Principal, DNA Bridges
* The NIH SBIR/STTR Program, NIAID Programs, and Electronic Submission
* Gregory Milman, PhD, Director, Office for Innovation and Special Programs, Division of Extramural Activities, NIAID, NIH
* Stem Cell Funding in California - An Update from CIRM
* Gilberto Sambrano, PhD, Scientific Review Officer, California Institute for Regenerative medicine (CIRM)
* IP Issues for Grant Applications
* Larry Hyman, JD MSc Townsend, Townsend, and Crew
* Panel: Innovative Philanthropic Foundations Fund Emerging Biotech
* Panelists include Kate Carr, President & CEO Accelerate Brain Cancer Cure (ABC2), and Robert Pacifici and Tom Base of CHDI, Inc., the not-for-profit drug discovery-development arm of High Q Foundation
* Panel: Incubators and Accelerator

In addition to the speakers, representatives from the following organizations and resources will be available for consultation.

· SRI/ Pharmastart
· QB3 Garage
· San Jose Bioscience Center
· MMRI
· Wilson Sonsini Goodrich Rosati
· Grant Writing Services
· Angel Investors

$75 if pre-registered and $150 at the event, cash or check only. The student/post-doc rate for attending this event is $35, if pre-registered. Register online at www.acteva.com/go/bioe2e. Pre-registration closes Tuesday, October 3.